.png)
.png)
Senior Research Scientist
Harvard T.H. Chan School of Public Health
Disclosure(s): No financial relationships to disclose
Carlee Moser, PhD is a Senior Research Scientist at the Center for Biostatistics in AIDS Research (CBAR) within the Department of Biostatistics at the Harvard T. H. Chan School of Public Health. She has extensive experience in statistical methods in epidemiology, observational studies, and clinical trials. Her primary role with in CBAR is as a senior statistician with the AIDS Clinical Trials Group (ACTG) where she has collaborated with clinical investigators on the development of clinical trial protocols, and has overseen the monitoring and analyses of studies. Recently, she took on the role of lead statistician working on the Operation Warp Speed platform trial of potential outpatient treatments for COVID-19. This trial is a major initiative of a collaboration between NIH, FDA and pharmaceutical companies known as ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines). The aim is to evaluate candidate monoclonal antibodies, and other immunological and antiviral agents using a standardized protocol with an adaptive design, including a possibly seamless phase 2 to phase 3 trial component.